Showing 11 - 20 of 98 results
Policy Snapshot
May 31, 2024
A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.
PALTmed In The News
August 23, 2024
Two new COVID vaccines were approved for use late last week, and experts continue to encourage seniors to get the booster, but payment issues for nursing homes and long-term care pharmacies complicate access for residents.
Spotlight
September 8, 2025
An update on the current approval status of COVID-19 vaccines, what it means for patients, pharmacies, and healthcare teams, and how PALTmed is supporting post-acute and long-term care providers during respiratory virus season.
JAMDA
July 20, 2021
Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...
JAMDA
February 15, 2019
Influenza is a leading cause of admissions for nursing home (NH) residents. We previously evaluated the effectiveness of a high-dose trivalent influenza vaccine (HD) compared to a standard-dose influenza vaccine (SD) through a cluster-randomized trial of NH residents. Fewer residents from facilities rando...
JAMDA
March 20, 2021
The vaccination of skilled nursing facility (SNF) staff is a critical component in the battle against COVID-19. Together, residents and staff constitute the single most vulnerable population in the pandemic. The health of these workers is completely entangled with the health of those they care for. Vaccina...
JAMDA
May 30, 2025
This study compares enhanced influenza vaccines recommended for older adults, adjuvanted flu vaccine (aTIV, FLUAD) vs high-dose flu vaccine (HD-IIV3, FLUZONE HD) to determine if they met noninferiority standards for older long-term care facility (LTCF) residents.
JAMDA
June 7, 2023
To investigate the association of using informal sources and reliance on multiple sources of information with actual COVID-19 vaccine uptake, the number of doses of vaccine received, COVID-19 testing, essential preventive measures, and perceived severity of COVID-19.
JAMDA
January 6, 2023
To assess the federal COVID-19 vaccine mandate's effects on nursing homes' nurse aide and licensed nurse staffing levels in states both with and without state-level vaccine mandates.
JAMDA
February 23, 2022
To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19.